XELTIS BV - NL 

Ranking results:

Past rankings:

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 3
As coordinator: 0
As participant: 2
Sole participant: 1
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 2.481.701 0 2.481.701 1
2021 0 5.410.693 640.000 1
2017 0 3.035.550 443.675 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
4REALSIM SERVICES BV1
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM1
ASSOCIATION POUR LA RECHERCHE ET LE DEVELOPPEMENT DES METHODES ET PROCESSUS INDUSTRIELS1
CAPVIDIA1
DUALIS MEDTECH1
EMTEC GMBH WERNER HEINZE1
GROUPE DES ECOLES DES TELECOMMUNICATIONS1
ISTITUTO MEDITERRANEO PER I TRAPIANTI E TERAPIE AD ALTA SPECIALIZZAZIONE SRL ISMETT1
KATHOLIEKE UNIVERSITEIT LEUVEN1
LEARTIKER SCOOP1
SCUOLA SUPERIORE DI STUDI UNIVERSITARI E DI PERFEZIONAMENTO SANT'ANNA1
STICHTING NEDERLANDSE WETENSCHAPPELIJK ONDERZOEK INSTITUTEN1
TECHNISCHE UNIVERSITAET GRAZ1
TECHNISCHE UNIVERSITEIT EINDHOVEN1
UNIVERSITA DEGLI STUDI DI PALERMO1

Constancy:

Total number of partners: 15
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 15
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2022-12-01Next-generation heart bypass grafts to naturally restore cardiovascular function. HeartRestorecoordinator2.481.7011
2021-01-01In-silico Development- and Clinical-Trial-Platform for Testing in-situ Tissue Engineered Heart Valves SimInSituparticipant5.410.69310
2017-11-01Development of the first fully biocompatible, soft actuated heart: combining in situ tissue engineering and soft robotics HybridHeartparticipant3.035.5507